Amarin reported $311.2M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
DBV Technologies USD 370M 113M Sep/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025